Champions Oncology Inc. (CSBR)
NASDAQ: CSBR
· Real-Time Price · USD
6.53
0.01 (0.15%)
At close: Aug 15, 2025, 3:59 PM
6.52
-0.15%
After-hours: Aug 15, 2025, 04:00 PM EDT
Champions Oncology Income Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Revenue | n/a | 17.04M | 13.49M | 14.06M | 14M | 12.02M | 11.57M | 12.56M | 13.07M | 12.77M | 14.28M | 13.74M | 12.88M | 13.19M | 11.79M | 11.25M | 10.56M | 10.81M | 10.12M | 9.55M |
Cost of Revenue | 7.27M | 6.62M | 7.07M | 7.07M | 7.25M | 7.85M | 6.62M | 7.68M | 7.34M | 7.7M | 7.44M | 7.05M | 6.22M | 6.41M | 5.61M | 5.4M | 5.65M | 4.84M | 5.64M | 5.34M |
Gross Profit | -7.27M | 10.42M | 6.42M | 6.99M | 6.75M | 4.17M | 4.96M | 4.88M | 5.73M | 5.07M | 6.84M | 6.69M | 6.66M | 6.79M | 6.18M | 5.86M | 4.91M | 5.97M | 4.47M | 4.21M |
Operating Income | -2.01M | 4.5M | 732K | 1.33M | 164K | -2.58M | -1.96M | -2.55M | -1.71M | -2.46M | 7K | -284K | -311K | 830K | 263K | -175K | -456K | 763K | 7K | 24K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.96M | 4.52M | 739K | 1.33M | -191K | -2.52M | -2.06M | -2.54M | -2.54M | -2.42M | -2K | -302K | -346K | 798K | 289K | -158K | -449K | 755K | 16K | 88K |
Net Income | -1.83M | 4.5M | 728K | 1.31M | -109K | -2.53M | -2.07M | -2.57M | -2.56M | -2.44M | -16K | -319K | -344K | 787K | 277K | -172K | -481K | 740K | 1K | 75K |
Selling & General & Admin | 4.83M | 4.2M | 3.64M | 4.21M | 4.54M | 4.56M | 4.39M | 4.64M | 4.59M | 4.33M | 4.23M | 4.09M | 4.38M | 3.78M | 3.62M | 3.73M | 3.3M | 3.33M | 2.82M | 2.59M |
Research & Development | 1.96M | 1.72M | 1.69M | 1.45M | 2.05M | 2.19M | 2.52M | 2.79M | 2.85M | 3.2M | 2.6M | 2.89M | 2.59M | 2.18M | 2.3M | 2.3M | 2.07M | 1.88M | 1.65M | 1.6M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 58K | n/a | 14K | -20K | n/a | -9K | -18K | -35K | -32K | 26K | 17K | 7K | -8K | 9K | n/a |
Operating Expenses | 6.8M | 5.92M | 5.33M | 5.66M | 6.59M | 6.75M | 6.91M | 7.43M | 7.45M | 7.53M | 6.83M | 6.98M | 6.97M | 5.96M | 5.91M | 6.03M | 5.37M | 5.21M | 4.47M | 4.19M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 584K | n/a | 9K | 18K | n/a | 32K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 2.31M | 1.81M | 1.75M | 1.68M | 1.78M | 1.8M | 1.79M | 1.7M | 1.85M | 1.76M | 1.7M | 1.69M | 1.61M | 1.55M | 1.64M | 1.57M | 1.47M | 1.49M | 1.35M | 1.21M |
Cost & Expenses | 14.07M | 12.54M | 12.4M | 12.73M | 13.84M | 14.6M | 13.53M | 15.11M | 14.79M | 15.23M | 14.27M | 14.03M | 13.19M | 12.36M | 11.52M | 11.43M | 11.02M | 10.05M | 10.11M | 9.52M |
Income Tax Expense | -130K | 23K | 11K | 21K | -82K | 11K | 11K | 28K | 20K | 17K | 14K | 17K | -2K | 11K | 12K | 14K | 32K | 15K | 15K | 13K |
Shares Outstanding (Basic) | 13.75M | 13.7M | 13.59M | 13.59M | 13.59M | 13.59M | 13.5M | 13.51M | 13.54M | 13.55M | 13.53M | 13.52M | 13.28M | 13.5M | 13.43M | 13.4M | 13.4M | 13.37M | 13.06M | 12.73M |
Shares Outstanding (Diluted) | 13.75M | 14.36M | 14.02M | 14.04M | 13.59M | 13.59M | 13.5M | 13.51M | 13.54M | 13.56M | 13.53M | 13.52M | 13.51M | 14.39M | 14.55M | 13.4M | 13.4M | 14.51M | 15.06M | 14.23M |
EPS (Basic) | -0.13 | 0.33 | 0.05 | 0.10 | -0.01 | -0.19 | -0.15 | -0.19 | -0.19 | -0.18 | -0.00 | -0.02 | -0.03 | 0.06 | 0.02 | -0.01 | -0.04 | 0.07 | 0.00 | 0.01 |
EPS (Diluted) | -0.13 | 0.31 | 0.05 | 0.09 | -0.01 | -0.19 | -0.15 | -0.19 | -0.19 | -0.18 | -0.00 | -0.02 | -0.03 | 0.05 | 0.02 | -0.01 | -0.04 | 0.07 | 0.00 | 0.01 |
EBITDA | -2.01M | 4.92M | 1.13M | 1.78M | 621K | -2.1M | -1.47M | -2.11M | -1.13M | -1.88M | 7K | 244K | 257K | 830K | 609K | 142K | 26K | 1.28M | 314K | 301K |
EBIT | n/a | 4.5M | 732K | 1.33M | -191K | -2.58M | -1.96M | -2.55M | -1.71M | -2.46M | -2K | -284K | -311K | 798K | 289K | -175K | -449K | 755K | 16K | 88K |
Depreciation & Amortization | n/a | 398K | 399K | 449K | 457K | 1.26M | 484K | 445K | 718K | 575K | 833K | 797K | 819K | 412K | 620K | 562K | 475K | 297K | 307K | 277K |